Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beiersdorf prelim sales, earnings down in 2009

This article was originally published in The Rose Sheet

Executive Summary

Hamburg, Germany-based firm records preliminary sales of €5.7 bil. ($8.3 bil.) for fiscal 2009, down 3.6 percent from the year prior. Sales in its consumer business segment, which includes Eucerin and NIVEA brands, were down 2.2 percent to €5.01 bil. ($7.2 bil.), though organic sales of the unit increased 1.2 percent. Although sales in Western Europe declined, revenues in the U.S., China and Latin America rose. Profit after taxes fell 33 percent to €379 mil. ($544.8 mil.). Beiersdorf's final results for the fiscal year will be released at an analyst meeting March 4

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel